CTEng URM and Student with Disabilities Outcomes

URM and Student with Disabilities

Percentage of number of URM and student with disabilities in the program and graduated: 18% (7 out 40), 100% graduated

Career placement of those students: 

  • Biotech – 29% - Gatan, Parkinson’s Association
  • Government Science – 29% - CDC, CIA
  • Pharma – 14% - Capricor
  • Regulatory Science -14% - FDA
  • Scientific Writing – 14% - Project Lead the Way

CTEng Alumni Profiles

Andres Bratt-Leal, Ph.D.

In Dr. Todd McDevitt's lab, my research focused on directing stem cell behavior within a three-dimensonal model system of differentiation. By incorporating biomaterial microparticles within aggregates of stem cells, I was able to deliver growth factors in a spatially controlled way that makes tissue engineering of early developmental structures easier. After graduating from Georgia Tech, I began a postdoctoral fellowship at The Scripps Research Institute with Dr. Jeanne Loring studying dopaminergic differentiation from induced pluripotent stem cells made from the skin of Parkinson's disease patients. Today, I am Senior Scientist at the Parkinson's Association where, together with Dr. Loring, I lead a team working to develop a stem cell-based therapy for Parkinson's disease. I'm grateful for the support provided by the tissue engineering training grant and for the opportunities to expand my network both in industry and academia.  

Ivana Parker, Ph.D.

Ivana worked to investigate the role of cathepsins, potent elastases and collagenases, in the progression of HIV - related cardiovascular disease with Dr. Manu Platt. Her research investigated the effects of hemodynamic environment and  HIV-proteins or antiretroviral regiment on cathepsin activity in arterial cells. This work was performed using an HIV-tg mouse model, and verified using human endothelial cells systems and a shear stress bioreactor. Her work demonstrated that the upregulation of cathepsins in vivo and in vitro is caused by a synergism between pro-atherogenic shear stress and HIV-1 proteins and elucidated pathways that are activated by HIV-1 Tat and pro-atherogenic shear stress - leading to cathepsin-mediated ECM degradation. 

She recently received the ASM/CDC Program in Infection Disease and Public Health Microbiology Postdoctoral Research Fellowship where she will be working  at the National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID). Her work there will aim to improve the monitoring of HIV incidence, the number of new infections, by developing bioplex assays, and identifying biomarkers for accurate recent infection detection.